BPC-157 Overview BPC-157 is a small protein fragment (peptide) made up of 15 amino acids
Physician-reviewed content Evidence-aware care Personalized treatment planning Use the Form That Fits the Pattern Patients in Cape Coral and nearby communities often compare B12 options for energy, focus, nerve support, diet-related deficiency, or post-surgical absorption concerns
Gramer G, Hoffmann GF (2020) Vitamin B12 deficiency in newborns and their mothersnovel approaches to early detection, treatment and prevention of a global health issue
Thymosin beta-4 has been hypothesized as an effective remyelination treatment based on its ability to promote differentiation of oligodendrocyte progenitor cells (OPCs)
Side effects are uncommon and typically mild: BPC-157: Injection-site irritation, occasional transient nausea, mild fatigue in the first week of a cycle
The peptides discussed here are not approved by the FDA for the uses described, and nothing on this page is a recommendation to obtain, self-administer, or dose them